Lumida
/REGN
⌘K
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc

REGN
$781.49USD↓-1.48%-11.77 today

MARKET CAP

80.5B

P/E (TTM)

16.9x

FWD P/E

12.8x

DAY RANGE

$781 – $800

52W RANGE

$541
$859

AI Summary

Stalk
StalkMedium

REGN is in a modest pullback within its longer-term uptrend. Short-term technicals show price under declining 9/20 EMAs and RSI drifting lower, suggesting room for mean-reversion toward the rising 50-day SMA around the 751 area. The medium-term stage 2 uptrend remains intact, so buying on a pullback into the 780–750 support zone is preferred. Execution should be deferred (stalk) for confirmation of support and improving momentum near the 50-day SMA before initiating new exposure.

  • ↑Q2 revenue $4.3B (+17% YoY) and Dupixent sales $6B (+38% YoY)
  • ↑Pipeline of ~50 active trials, with oncology and genetic therapies advancing
  • ↓Dupixent dependency creates revenue risk if growth slows
Full analysis →

Buying

14

institutions

Selling

8

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY9.11 M5.68 B+165.77 K-17.8%0.08%
JC

Jpmorgan Chase & Co

Q2 2026

SELL3.77 M2.38 B+-537.61 K-26.2%0.14%
AC

Aqr Capital Management LLC

Q2 2026

SELL1.13 M702.16 M+-104.93 K-25.8%0.24%
CA

Citadel Advisors LLC

Q2 2026

BUY593.50 K370.07 M+159.72 K+10.4%0.04%
JH

Janus Henderson Group Plc

Q1 2026

BUY418.50 K323.27 M+212.82 K+103.6%0.08%
MG

Man Group Plc

Q2 2026

BUY436.96 K272.46 M+121.74 K+11.9%0.44%
MM

Millennium Management LLC

Q2 2026

BUY235.62 K146.92 M+103.39 K+43.8%0.05%
CP

California Public Employees Retirement System

Q2 2026

BUY224.27 K139.84 M+5.50 K-17.3%0.08%
VI

Voloridge Investment Management, LLC

Q2 2026

BUY163.96 K102.24 M+148.60 K+761.3%0.44%
RT

Renaissance Technologies LLC

Q2 2026

BUY148.22 K92.42 M+81.42 K+79.1%0.13%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

BUY74.20 K46.27 M+18.85 K+8.2%0.10%
WP

Woodline Partners LP

Q2 2026

SELL72.59 K45.27 M+-62.91 K-56.8%0.14%
BA

Bridgewater Associates, LP

Q2 2026

BUY51.33 K32.01 M+28.61 K+82.3%0.13%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY23.53 K14.67 M+19.33 K+351.6%0.02%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY22.21 K13.85 M+10.05 K+47.5%0.64%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL21.56 K13.45 M+-6.96 K-39.0%0.02%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUYNEW5.25 K3.27 M+5.25 K+0.0%0.75%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL2.00 K1.25 M+-148.57 K-98.9%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY1.98 K1.23 M+1.65 K+378.2%0.01%
SA

Scion Asset Management, LLC

Q3 2025

SELL0.000.00+-215.00 K-100.0%0.00%
FA

Fisher Asset Management, LLC

Q2 2026

SELL0.000.00+-5.06 K-100.0%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL0.000.00+-267.00-100.0%0.00%